EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

2950 reported adverse events

Drug classes: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]

These side effects are most commonly reported by patients taking EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE:

# Side effect Count
0 NAUSEA 213
1 BLOOD GLUCOSE INCREASED 192
2 VOMITING 189
3 DIARRHOEA 158
4 DIABETIC KETOACIDOSIS 156
5 WEIGHT DECREASED 144
6 FATIGUE 131
7 KETOACIDOSIS 124
8 DRUG INEFFECTIVE 117
9 DIZZINESS 109
See all common reactions for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 STOMACH SCAN ABNORMAL 5 0.1786
1 SYNOVIAL DISORDER 25 0.0549
2 ALLERGIC SINUSITIS 25 0.0291
3 COMPLEMENT FACTOR C3 DECREASED 5 0.0205
4 PERINEAL INFECTION 4 0.0202
5 EUGLYCAEMIC DIABETIC KETOACIDOSIS 81 0.0196
6 KETONURIA 14 0.0172
7 KETOACIDOSIS 124 0.0166
8 VITAMIN B12 DECREASED 25 0.0087
9 URETHRAL PAIN 5 0.0085
See all enriched reactions for EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE